Cmpx stock forecast.

We've seen plenty of personal finance tools designed to help you track what you're spending, but web site PocketSmith is an impressive new web-based personal finance tool with an emphasis on forecasting your financial future. We've seen ple...CMPX: Compass Therapeutics, Inc. - Price and Consensus Chart. Get the latest Price and Consensus Chart for Compass Therapeutics, Inc. from Zacks Investment ResearchGreat weather can motivate you to get out of the house, while inclement weather can make you feel lethargic. When the weather’s great we want to be outside enjoying it. For the best regional weather forecasts check out AccuWeather.A convolutional neural network (CNN) is applied to forecast stock price changes in the Chinese stock market. We use 27 technical indicators and 5 original price series as benchmark models and ...

According to the issued ratings of 4 analysts in the last year, the consensus rating for Catalyst Pharmaceuticals stock is Buy based on the current 4 buy ratings for CPRX. The average twelve-month price prediction for Catalyst Pharmaceuticals is $24.75 with a high price target of $27.00 and a low price target of $24.00.The consensus price target of analysts on Wall Street is $9.17, which implies an increase of 82.01% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $8.00 and $11.00 respectively. As a result, CMPX is trading at a discount of -566.67% off the target high and -384.85% off the low.Dec 1, 2023 · The stock of Compass Therapeutics Inc (CMPX) has gone down by -4.07% for the week, with a -8.33% drop in the past month and a -29.18% drop in the past quarter. The volatility ratio for the week is 4.13%, and the volatility levels for the past 30 days are 7.49% for CMPX. The simple moving […]

Wall Street Stock Market & Finance report, prediction for the future: You'll find the Compx International, Inc. - Class A share forecasts, stock quote and buy / sell signals below. According to present data Compx International, Inc. - Class A's CIX shares and potentially its market environment have been in a bullish cycle in the last 12 months ...

Analyst Forecast. According to 4 analysts, the average rating for CMPX stock is "Strong Buy." The 12-month stock price forecast is $9.33, which is an increase …The consensus price target of analysts on Wall Street is $9.17, which implies an increase of 78.95% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $8.00 and $11.00 respectively. As a result, CMPX is trading at a discount of -469.95% off the target high and -314.51% off the low.Previous Close $3.68. Volume 32.29K. Average Volume (3M) 157.25K. Market Cap. $1.22B. Enterprise Value $963.30M. Total Cash (Recent Filing) $259.49M. Total Debt (Recent Filing) $921.00K. Price to Earnings (P/E) -5.0.Stock Price Forecast. The 1 analysts offering 12-month price forecasts for CompX International Inc have a median target of 24.00, with a high estimate of 24.00 and a low estimate of 24.00. The ...

Get free stock tools, free stock ratings, free stock charts and calculate the value of stocks to buy

The underwriters may also purchase up to an additional shares of our common stock at the public offering price, less the underwriting discounts and commissions ...

Compx International Inc: A High-Performing Stock with a GF Score of 93. GF Score analysis. Find the latest CompX International Inc. (CIX) stock quote, history, news and other vital information to ... The 6 analysts offering 1 year price forecasts for CMPX have a max estimate of — and a min estimate of —. Analyst rating Based on 6 analysts giving stock ratings to CMPX in the past 3 months. Their COEP share price targets range from $3.00 to $6.00. On average, they expect the company's stock price to reach $4.33 in the next twelve months. This suggests a possible upside of 270.4% from the stock's current price. View analysts price targets for COEP or view top-rated stocks among Wall Street analysts.Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.BOSTON, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer ...Stock Price Forecast. The 1 analysts offering 12-month price forecasts for CompX International Inc have a median target of 24.00, with a high estimate of 24.00 and a low estimate of 24.00. The ...

According to the issued ratings of 4 analysts in the last year, the consensus rating for Catalyst Pharmaceuticals stock is Buy based on the current 4 buy ratings for CPRX. The average twelve-month price prediction for Catalyst Pharmaceuticals is $24.75 with a high price target of $27.00 and a low price target of $24.00.Compass Therapeutics Inc. (CMPX) stock is trading at $3.95 as of 12:48 PM on Tuesday, Jan 31, an increase of $0.10, or 2.6% from the previous closing price of $3.85. The stock has traded between $3.88 and $4.13 so far today. Volume today is less active than usual.CMPX : 3.36 (+8.74%) Compass Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update Globe Newswire - Mon Mar 21, 2022. Ended 2021 with $144.5 million in cash and cash equivalentsCTX-009 (DLL4 X VEGF-A bispecific antibody) Global Phase 2 study in patients with advanced...The CompX International stock forecast for tomorrow is $ 23.75, which would represent a -1.06% loss compared to the current price. In the next week, the price of CIX is expected to decrease by -9.90% and hit $ 21.62. As far as the long-term CompX International stock forecast is concerned, here ... Source: YCharts. Management said during the company's 2022 investor day in June last year that it expects long-term annual revenue growth of 20%. Assuming AMD's top line grows at an annual pace of ...Find the latest ProShares UltraPro Short QQQ (SQQQ) stock quote, history, news and other vital information to help you with your stock trading and investing.Compx International Inc: A High-Performing Stock with a GF Score of 93. GF Score analysis. Find the latest CompX International Inc. (CIX) stock quote, history, news and other vital information to ...

CMPX Stock Price Chart Interactive Chart > Compass Therapeutics Inc. (CMPX) Company Bio. Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. immuno-oncology product candidates include a clinical-stage monoclonal antibody targeting solid tumors, a novel …Wall Street Stock Market & Finance report, prediction for the future: You'll find the Compx International, Inc. - Class A share forecasts, stock quote and buy / sell signals below. According to present data Compx International, Inc. - Class A's CIX shares and potentially its market environment have been in a bullish cycle in the last 12 months ...

News Ideas Financials Technicals Forecast CMPX chart Today 2.59% 5 days 2.06% 1 month 3.66% 6 months −31.25% Year to date −61.10% 1 year −34.44% 5 years −76.71% All time −76.71% Key stats Market capitalization 252.37M USD Dividends yield (FY) — Price to earnings Ratio (TTM) — Basic EPS (TTM) −0.37 USD Net income −39.225M USD Revenue — Shares floatThe 6 analysts offering 1 year price forecasts for CMPX have a max estimate of — and a min estimate of —. Analyst rating Based on 6 analysts giving stock ratings to CMPX in …In many cases to predict stock price, gold and crude oil have been used as extra indicators [36], in some of the works, 43 technical indicators as input features along with LSTM to forecast price ...Find the latest Compass Therapeutics, Inc. (CMPX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.66.07%. Get the latest Compass Therapeutics Inc. (CMPX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ... Stock Price Forecast. According to 4 stock analysts, the average 12-month stock price forecast for CMPX stock stock is $9.33, which predicts an increase …The above table shows the analyst CMPX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$1.77Learn more about whether Compass Therapeutics Inc. is a good stock to buy or sell based on recent news as well as its key financial metrics. Read on to find out how grades on certain investment factors and determine whether it meets your investment needs.. Latest Compass Therapeutics Inc. Stock News

Wall Street Stock Market & Finance report, prediction for the future: You'll find the Compx International, Inc. - Class A share forecasts, stock quote and buy / sell signals below. According to present data Compx International, Inc. - Class A's CIX shares and potentially its market environment have been in a bullish cycle in the last 12 months ...

CMPX stock forecast Our latest prediction for Compass Therapeutics Inc's stock price was made on the March 15, 2023 when the stock price was at 3.56$. In the short term (2weeks), CMPX's stock price should underperform the market by -2.94%. During that period the price should oscillate between -8.72% and +5.46%.

The Compx International, Inc. - Class A stock forecast is 40.29786370896 USD for 2024 November 25, Monday; and 148.757 USD for 2028 November 25, Saturday with technical analysis. Compx International, Inc. - Class A (CIX) stock price prediction is 40.29786370896 USD.With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.According to the issued ratings of 6 analysts in the last year, the consensus rating for Mesoblast stock is Hold based on the current 1 sell rating, 3 hold ratings and 2 buy ratings for MESO. The average twelve-month price prediction for Mesoblast is $7.13 with a high price target of $17.00 and a low price target of $1.50.Stock Price Forecast. According to 4 stock analysts, the average 12-month stock price forecast for CMPX stock stock is $9.33, which predicts an increase …Nov 18, 2023 · It follows that stock’s current price would drop -591.82% in reaching the projected high whereas dropping to the targeted low would mean a loss of -403.14% for stock’s current value. Compass Therapeutics Inc (CMPX) estimates and forecasts Total Valuation. CMPX has a market cap or net worth of $224.33 million. The enterprise value is $55.37 million. Market Cap. 224.33M. Enterprise Value. 55.37M.Compass Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CMPX updated stock price target summary. CMPX Stock Price Chart Interactive Chart > Compass Therapeutics Inc. (CMPX) Company Bio. Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. immuno-oncology product candidates include a clinical-stage monoclonal antibody targeting solid tumors, a novel …About Compass Therapeutics. Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass’s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth.Stock Price Forecast. The 5 analysts offering 12-month price forecasts for CompoSecure Inc have a median target of 13.00, with a high estimate of 15.00 and a low estimate of 7.00. The median ... Stock analysis for Compass Therapeutics Inc (CMPX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Nov 15, 2023 · The projected low price target is $8.00 while the price target rests at a high of $11.00. In that case, then, we find that the current price level is -618.95% off the targeted high while a plunge would see the stock gain -422.88% from current levels. Compass Therapeutics Inc (CMPX) estimates and forecasts What is the difference between Tesla's targeted high price and its latest price? ... Stock comparison. Financial metrics over time. Search other exchanges. News ...The above table shows the analyst CMPX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$1.77Get The Latest TVE Stock Analysis, Price Target, Dividend Info, and Headlines at MarketBeat. ... View our TVE earnings forecast. How were Tamarack Valley Energy's earnings last quarter? Tamarack Valley Energy Ltd (TSE:TVE) issued its quarterly earnings data on Thursday, October, 26th. The company reported $0.02 EPS …Instagram:https://instagram. the next amazon stockacretrader reviewrobinhood futuresis brics a threat to the us dollar SFIX Stock 12 Months Forecast. $3.68. (5.75% Upside) Based on 10 Wall Street analysts offering 12 month price targets for Stitch Fix in the last 3 months. The average price target is $3.68 with a high forecast of $5.00 and a low forecast of $2.50. The average price target represents a 5.75% change from the last price of $3.48. brokerage account tax ratewater sewer insurance coverage If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti... 26 week treasury bill rates Jul 11, 2023 · CMPX Stock Forecast 2023. Compass Therapeutics boasts a robust drug pipeline, which explains why analysts are bullish on the stock. The Phase 2 and Phase 3 studies for cancer drug CTX-009 extend into H2 2023, at which time the company plans to initiate a Phase 1 study for its CTX-8371 drug also for cancer after filing an Investigational New Drug Application (IND) earlier in 2023. Stock Price Forecast. The 5 analysts offering 12-month price forecasts for CompoSecure Inc have a median target of 13.00, with a high estimate of 15.00 and a low estimate of 7.00. The median ...